QIAGEN N.V. | 41.21 / +0.76% |
Date/Time | 03/01 / 13:34 |
Chg. / Chg.(%) | 0.31 / +0.76% |
Bid | 41.19 / 115 |
Ask | 41.21 / 119 |
Open | 41.71 |
Previous Close | 40.90 |
High | 41.71 |
Low | 41.12 |
Volume [EUR] | 2,275,130.30 |
Volume [Units] | 55,151 |
Price fixings | 435 |
ISIN | NL0012169213 |
Security | QIA/D |
Exchange | Turquoise |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Xetra | 41.200 | ![]() |
138,093 |
Cboe Europe .. | 41.20 | ![]() |
59,294 |
Turquoise | 41.21 | ![]() |
55,151 |
TradeGate | 41.21 | ![]() |
13,490 |
London Inter.. | 41.21 | ![]() |
5,651 |
Stuttgart | 41.210 | ![]() |
1,190 |
Frankfurt | 41.1500 | ![]() |
1,098 |
gettex | 41.180 | ![]() |
206 |
Hamburg | 42.190 | ![]() |
150 |
Berlin | 41.910 | ![]() |
3 |
München | 41.610 | ![]() |
0 |
Düsseldorf | 41.190 | ![]() |
0 |
Hannover | 41.910 | ![]() |
0 |
Lang & Schwa.. | 41.190 | ![]() |
|
NYSE | 50.00 | ![]() |
919,789 |
IEX | 50.03 | ![]() |
37,140 |
Cboe US | 50.02 | 14,351 | |
Cboe Europe .. | 40.87 | 40 | |
Vienna Globa.. | 40.92 | 0 | |
Cboe Europe .. | 41.48 | 388 | |
EUREX | Options |
News
- OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
12/09/2020 / 13:30 - GlobeNewswire - HTG Molecular Diagnostics Reports Third Quarter 2020 Results
11/10/2020 / 22:01 - GlobeNewswire - Ellume Secures $30M from National Institutes of Health RADx Initiative to Accelerate Development of Rapid COVID-19 Diagnostics
10/06/2020 / 21:30 - GlobeNewswire - Thermo Fisher's acquisition of Qiagen fails
08/13/2020 / 13:48 - TeleTrader - HTG Molecular Diagnostics Reports Second Quarter 2020 Results
08/11/2020 / 22:01 - GlobeNewswire